Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Assessment of Optic Nerve Impairment in Patients with Neuromyelitis Optica by MR Diffusion Tensor Imaging.
Differentiation of neuromyelitis optica spectrum disorders from ultra-longitudinally extensive transverse myelitis in a cohort of Chinese patients.
Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review.
[Treatment of neuromyelitis optica].
Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs).
The role of Ets2 transcription factor in the induction of microRNA-155 by LPS, and its targeting by IL-10.
Spanish consensus on the use of natalizumab (Tysabri(®))-2013.
FTY720 for cancer therapy (Review).
Alternative data sources for estimating multiple sclerosis prevalence.
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.
The effect of whole-body, repetitive, inhomogeneous static magnetic field-exposure on the symptoms of experimental autoimmune encephalomyelitis in mice.
Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.
In Vivo Quantification of Inflammation in Experimental Autoimmune Encephalomyelitis Rats Using Fluorine-19 Magnetic Resonance Imaging Reveals Immune Cell Recruitment outside the Nervous System.
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells.
[Anesthetic management of a Dialysis Patient with Chronic Inflammatory Demyelinating Polyneuropathy].
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis.
Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.
Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain.
Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors.
Analysis of miRNA in Normal Appearing White Matter to Identify Altered CNS Pathways in Multiple Sclerosis.
Early diagnosis of Balo's concentric sclerosis by diffusion tensor tractography: a case report and literature review.
FGF8 Activates Proliferation and Migration in Mouse Post-Natal Oligodendrocyte Progenitor Cells.
Pages
« first
‹ previous
…
531
532
533
534
535
536
537
538
539
…
next ›
last »